pms-Ranitidine 150mg (2020-08-28)
- Starting date:
- August 28, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73873
Last updated:
2020-09-02
Summary
-
Product:
pms-Ranitidine 150mg
Reason
Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lot.
Depth of distribution
Wholesalers, Retailers, Healthcare establishments
Affected products
pms-Ranitidine 150mg
DIN, NPN, DIN-HIM
DIN 02242453
Dosage form
Tablet
Strength
Ranitidine Hydrochloride 150mg
Lot or serial number
619003
Companies
- Recalling Firm
-
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
611 ave Royalmount suite 100
Montreal
H4P 2T4
Quebec
CANADA